BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17587845)

  • 1. Exacerbation of pityriasis rubra pilaris under efalizumab therapy.
    Klein A; Szeimies RM; Landthaler M; Karrer S
    Dermatology; 2007; 215(1):72-5. PubMed ID: 17587845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of atypical adult pityriasis rubra pilaris with oral alitretinoin.
    Pampín A; Gómez-de la Fuente E; Caro Gutiérrez MD; López-Estebaranz JL
    J Am Acad Dermatol; 2013 Aug; 69(2):e105-6. PubMed ID: 23866882
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrodermic pityriasis rubra pilaris: Dramatic response to infliximab therapy.
    Karadag AS; Kavala M; Ozlu E; Ozkanlı S; Zindancı İ; Turkoglu Z
    Indian J Dermatol Venereol Leprol; 2016; 82(1):112. PubMed ID: 26728835
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment.
    Karimian-Teherani D; Parissa M; Tanew A
    Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris.
    Bonomo L; Levitt JO
    Cutis; 2018 May; 101(5):367-369. PubMed ID: 29894526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pityriasis rubra pilaris. Case reports and review of the literature].
    Artik S; Megahed M; Ruzicka T
    Hautarzt; 2003 Sep; 54(9):858-63. PubMed ID: 12955264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pityriasis rubra pilaris].
    Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of adult-onset pityriasis rubra pilaris.
    Liao WC; Mutasim DF
    Arch Dermatol; 2005 Apr; 141(4):423-5. PubMed ID: 15837858
    [No Abstract]   [Full Text] [Related]  

  • 14. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate.
    Barth D; Harth W; Treudler R; Simon JC
    J Dtsch Dermatol Ges; 2009 Dec; 7(12):1071-4. PubMed ID: 19689446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy.
    Zhang YH; Zhou Y; Ball N; Su MW; Xu JH; Zheng ZZ
    J Cutan Med Surg; 2010; 14(4):185-8. PubMed ID: 20642989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.